These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23279907)

  • 1. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
    Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
    Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
    Filizola M; Harris DL; Loew GH
    J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
    Vijayan RS; Ghoshal N
    J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABA A/BzR subtypes alphaxbeta3gamma2 [x = 1-3, 5, and 6] via flexible atom receptor model.
    Lu A; Zhou J
    J Chem Inf Comput Sci; 2004; 44(3):1130-6. PubMed ID: 15154782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
    Reddy KK; Singh SK
    Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
    Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
    J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.
    Harris DL; DeLorey TM; He X; Cook JM; Loew GH
    Eur J Pharmacol; 2000 Aug; 401(3):271-87. PubMed ID: 10936485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.
    Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y
    J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
    Malla P; Kumar R; Kumar M
    Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies.
    Contreras-Romo MC; Martínez-Archundia M; Deeb O; Slusarz MJ; Ramírez-Salinas G; Garduño-Juárez R; Quintanar-Stephano A; Ramírez-Galicia G; Correa-Basurto J
    Chem Biol Drug Des; 2014 Feb; 83(2):207-23. PubMed ID: 24010681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
    Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
    Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
    Oberdorf C; Schmidt TJ; Wünsch B
    Eur J Med Chem; 2010 Jul; 45(7):3116-24. PubMed ID: 20427100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
    Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
    J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, comprehensive 3D-QSAR, and binding mode analysis of TGR5 agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2017 Apr; 37(2):109-123. PubMed ID: 27267434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
    Reddy KK; Singh SK; Tripathi SK; Selvaraj C
    SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.